Mr. Felix Asamoah, BS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1574 N Dupont Hwy, Dover, DE 19901 Phone: 302-674-4827 |
Dr. Celeste Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7018 |
Mr. David William Dryden, R.PH., ESQ. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 861 Silver Lake Blvd, Dover, DE 19904 Phone: 302-744-4527 Fax: 302-739-2711 |
Mr. Louis Elliott Levenson, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Bayhealth Medical Center Department Of Pharmacy Svcs, Dover, DE 19901 Phone: 302-744-6921 |
Janet Binder, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 196 Fawn Haven Walk, Dover, DE 19901 Phone: 302-698-3222 |
Dr. Peter Agbo, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5506 S Dupont Hwy, Dover, DE 19901 Phone: 302-698-6320 |
Jordan Woodall, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-6025 |
Jamessa D'andrea Cummings, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1074 S State St, Dover, DE 19901 Phone: 302-725-3200 |
Mrs. Toshiko N Reckner, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 36 Holly Cove Ln, Dover, DE 19901 Phone: 302-697-6407 |
Paul Michael Mayan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 20 N Dupont Hwy, Dover, DE 19901 Phone: 302-730-5280 Fax: 302-730-5285 |
Ravikiran Kumar Tatikonda, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1580 S Dupont Hwy, Dover, DE 19901 Phone: 302-734-4788 |
Olufunmilola Adebanjo Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Forrest Ave, Dover, DE 19904 Phone: 302-678-9820 |
Pieter Pretorius Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 N Dupont Hwy, Dover, DE 19901 Phone: 302-674-8392 |
Izetta Chaunte Henry, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1215 S State St, Dover, DE 19901 Phone: 302-730-1170 Fax: 302-730-8471 |
Mr. Erik Mason Mabus, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 200 W Loockerman St, Dover, DE 19904 Phone: 302-632-5149 Fax: 302-735-7556 |
Ubong Dominic Edet, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1278 Forrest Ave, Dover, DE 19904 Phone: 302-678-9820 |
Maria Fidelis Ilagan Romero, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 988 Forest St, Dover, DE 19904 Phone: 302-744-9222 |
Chinedum Amakwe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1580 S Dupont Hwy, Dover, DE 19901 Phone: 703-217-1900 |
Dr. Susan Muhumuza, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 640 S State St, Dover, DE 19901 Phone: 302-744-7018 |
Priti Patel Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 245 N Dupont Hwy, Dover, DE 19901 Phone: 302-674-2945 |
News Archive
Researchers conducting a comprehensive proteomics analysis of human aqueous humor samples identified 763 proteins - including 386 proteins detected for the first time - in this clear fluid that helps maintain pressure in the eye and nourishes the cornea and the lens.
Many eye diseases, including diabetic retinopathy and macular degeneration, exhibit increased permeability of blood vessels in the macular (central) portion of the retina leading to abnormal fluid accumulation and vision loss.
The Partnership for Supply Chain Management, a partner of the U.S. Agency for International Development under the U.S. President's Emergency Plan for AIDS Relief, has won two prestigious awards for groundbreaking work on PEPFAR's Supply Chain Management System. PFSCM received the Supply Chain Innovation Award and Best Value Supply Chain Provider Award during the European Supply Chain and Logistics Summit held in Prague.
Researchers reveal that being overweight and obese are common risk factors for developing severe COVID-19. However, they suggested further assessment of metabolic parameters, including body mass index (BMI), waist-hip ratio, and insulin levels, to estimate the risk.
BioCryst Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of treatments for rare and infectious diseases, today announced that it has submitted a New Drug Application (NDA) filing for intravenous (i.v.) peramivir to the U.S. Food & Drug Administration (FDA). BioCryst is seeking an indication as the first i.v. neuraminidase inhibitor approved in the U.S. for the treatment of acute uncomplicated influenza in adults. Peramivir is approved in Japan and Korea for the treatment of influenza.
› Verified 8 days ago